Pancreatic Cancer Research

ResearcherHuazhong University of Science and TechnologyActive in the last 2 years

Rong Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5060-895X; OpenAlex author ID A5063159905. Sources: OpenAlex.

Their work

Papers
18 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2013: 1 paper · 2014: 3 papers · 2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: 2 papers · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 18

  1. Author Correction: Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-025-58613-9↗
  2. Systematic analysis on expression quantitative trait loci identifies a novel regulatory variant in ring finger and WD repeat domain 3 associated with prognosis… Co-author DOI 10.1097/cm9.0000000000002180↗
  3. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Co-author DOI 10.1007/s00204-021-02978-5↗
  4. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Co-author DOI 10.1016/j.ejca.2021.04.008↗
  5. Evaluation of polymorphisms in microRNA-binding sites and pancreatic cancer risk in Chinese population. Co-author DOI 10.1111/jcmm.14906↗
  6. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Co-author DOI 10.1136/gutjnl-2019-320179↗
  7. A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population. Co-author DOI 10.1002/cam4.2228↗
  8. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Last author DOI 10.1002/mc.22968↗
  9. A functional variant in the boundary of a topological association domain is associated with pancreatic cancer risk. Co-author DOI 10.1002/mc.23077↗
  10. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-018-06136-x↗
  11. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population. Co-author DOI 10.18632/oncotarget.16422↗
  12. A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population. Co-author DOI 10.18632/oncotarget.11607↗
  13. Genetic variants in the SWI/SNF complex and smoking collaborate to modify the risk of pancreatic cancer in a Chinese population. Co-author DOI 10.1002/mc.22140↗
  14. SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer. Co-author DOI 10.18632/oncotarget.5647↗
  15. Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: evidence from a meta-analysis of 42 observational studies. First author DOI 10.1016/j.ejca.2013.08.014↗
  16. Parity and pancreatic cancer risk: evidence from a meta-analysis of twenty epidemiologic studies. Co-author DOI 10.1038/srep05313↗
  17. [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking]. Co-author PMID 25174478↗
  18. [Discussion on the strategy of prevention and control of pancreatic cancer]. First author PMID 24304947↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoping Miao · 17 shared papers, 2013–2025 · strength 1.30
  2. Jianbo Tian · 12 shared papers, 2016–2025 · strength 1.12
  3. Jiang Chang · 12 shared papers, 2016–2025 · strength 1.12
  4. Ying Zhu · 11 shared papers, 2016–2025 · strength 0.99
  5. Juntao Ke · 10 shared papers, 2014–2025 · strength 0.75
  6. Pingting Ying · 7 shared papers, 2019–2022 · strength 0.69
  7. Beibei Zhu · 8 shared papers, 2014–2025 · strength 0.50
  8. Kun Huang · 3 shared papers, 2017–2025 · strength 0.30
  9. Ming Zhang · 3 shared papers, 2019–2022 · strength 0.29
  10. Shufang Mei · 3 shared papers, 2019–2020 · strength 0.24
  11. Ming Yang · 2 shared papers, 2018–2025 · strength 0.24
  12. Li Wang · 2 shared papers, 2018–2025 · strength 0.24
  13. Chen Hsuan Wu · 2 shared papers, 2018–2025 · strength 0.24
  14. Dongxin Lin · 2 shared papers, 2018–2025 · strength 0.24
  15. Bin Li · 2 shared papers, 2019–2021 · strength 0.17
  16. Li Zou · 4 shared papers, 2014–2015 · strength 0.16
  17. Jing Tian · 3 shared papers, 2014–2015 · strength 0.13
  18. Yao Tian · 3 shared papers, 2014–2015 · strength 0.13
  19. Ying Zhu · 1 shared paper, 2022 · strength 0.13
  20. Li Wang · 2 shared papers, 2014–2015 · strength 0.09
  21. Beibei Zhu · 1 shared paper, 2019 · strength 0.08
  22. Xiaoping Miao · 1 shared paper, 2019 · strength 0.08
  23. Wei Chen · 2 shared papers, 2014 · strength 0.08
  24. Bei-bei Zhu · 1 shared paper, 2013 · strength 0.06
  25. Li Liu · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.